Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

CVS Considers “Piece” Of Eckerd, Sees Ample Room For Expansion

  • News

Executive Summary

CVS is interested in buying a "piece" of the drug store chain Eckerd "at the right price," CVS CFO David Rickard told analysts during the company's third quarter conference call Oct. 29

You may also be interested in...



Duane Reade Sale Reflects “Industry Issues”: First Rx Reimportation Victim?

Drug reimportation is among the pharmacy industry issues cited by the retail drug chain Duane Reade in explaining its decision to sell to the private equity firm Oak Hill Capital Partners

Duane Reade Sale Reflects “Industry Issues”: First Rx Reimportation Victim?

Drug reimportation is among the pharmacy industry issues cited by the retail drug chain Duane Reade in explaining its decision to sell to the private equity firm Oak Hill Capital Partners

Big Pharma’s “Black Wednesday”: Quarterly Reports Underscore Uncertainty

An unprecedented string of poor third-quarter earnings reports from the top pharmaceutical companies illustrates the importance of the Medicare debate to the future of the drug industry

Table

View full table

Related Content

Pink Sheet
Tags:
Latest Headlines

EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications

Industry & Regulators To Align Advice on COVID-19 Vaccine Updates

Lack Of Industry Involvement In EU HTA Scoping Process Exacerbates ‘Unworkable’ Timelines

CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings

See All
UsernamePublicRestriction

Register

PS042733

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By